Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentine M Macaulay

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Novartis Foundation Symposium|November 26, 2004
The IGF receptor as anticancer treatment targetValentine M Macaulay
Cells|August 17, 2019
Therapeutic Targeting of the IGF AxisEliot Osher, Valentine M Macaulay
Expert Opinion on Therapeutic Targets|April 16, 2008
Targeting the type 1 insulin-like growth factor receptor as a treatment for cancerJohn S P Yuen, Valentine M Macaulay
Biochemical and Biophysical Research Communications|February 27, 2007
Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cellsJohann Riedemann, Muhammad Sohail, Valentine M Macaulay
Biochemical and Biophysical Research Communications|February 20, 2007
The EGF receptor interacts with the type 1 IGF receptor and regulates its stabilityJohann Riedemann, Megumi Takiguchi, Muhammad Sohail, et al.
Anti-Cancer Drugs|October 11, 2003
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatmentErin A Bohula, Martin P Playford, Valentine M Macaulay
Cancer Treatment Reviews|August 16, 2014
Can we unlock the potential of IGF-1R inhibition in cancer therapy?Helen King, Tamara Aleksic, Paul Haluska, et al.
Molecular Oncology|May 7, 2026
Loss of IGF-1R impairs DNA-PKcs recruitment to chromatin leading to defective end-joiningMatthew O Ellis, Jack V Mills, Wojciech Niedzwiedz, et al.
Targeted Oncology|August 18, 2017
Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination StudiesAaron Simpson, Wilfride Petnga, Valentine M Macaulay, et al.
International Journal of Cancer|November 13, 2014
Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibitionKunal A Lodhia, Shan Gao, Tamara Aleksic, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Novartis Foundation Symposium|November 26, 2004
The IGF receptor as anticancer treatment targetValentine M Macaulay
Cells|August 17, 2019
Therapeutic Targeting of the IGF AxisEliot Osher, Valentine M Macaulay
Expert Opinion on Therapeutic Targets|April 16, 2008
Targeting the type 1 insulin-like growth factor receptor as a treatment for cancerJohn S P Yuen, Valentine M Macaulay
Biochemical and Biophysical Research Communications|February 27, 2007
Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cellsJohann Riedemann, Muhammad Sohail, Valentine M Macaulay
Biochemical and Biophysical Research Communications|February 20, 2007
The EGF receptor interacts with the type 1 IGF receptor and regulates its stabilityJohann Riedemann, Megumi Takiguchi, Muhammad Sohail, et al.
Anti-Cancer Drugs|October 11, 2003
Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatmentErin A Bohula, Martin P Playford, Valentine M Macaulay
Cancer Treatment Reviews|August 16, 2014
Can we unlock the potential of IGF-1R inhibition in cancer therapy?Helen King, Tamara Aleksic, Paul Haluska, et al.
Molecular Oncology|May 7, 2026
Loss of IGF-1R impairs DNA-PKcs recruitment to chromatin leading to defective end-joiningMatthew O Ellis, Jack V Mills, Wojciech Niedzwiedz, et al.
Targeted Oncology|August 18, 2017
Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination StudiesAaron Simpson, Wilfride Petnga, Valentine M Macaulay, et al.
International Journal of Cancer|November 13, 2014
Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibitionKunal A Lodhia, Shan Gao, Tamara Aleksic, et al.
Pageof 5